Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

324.71 +0.48 (+0.15%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Market Rally Hits Highs Amid Strong Earnings, Jobs; Square, GM, Etsy Among Key Movers
The Dow, S&P 500 and Nasdaq amid heavy earnings and a hot jobs report. Square, GM and Etsy were notable movers. 
Via Investor's Business Daily
Topics Stocks
Exposures Fossil Fuels US Equities
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
Innovent Biologics Inc (OTC: IVBIY) and Eli Lilly And Co (NYSE: LLY) have announced new and updated data from the ORIENT-11 Phase 3 study of sintilimab... 
Via Benzinga
Analyst Ratings For Eli Lilly
Analysts have provided the following ratings for Eli Lilly (NYSE:LLY) within ... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Analyzing Eli Lilly's Unusual Options Activity
On Wednesday, shares of Eli Lilly (NYSE:LLY) saw unusual opti... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021
Upgrades Stephens & Co. upgraded the previous rating for Roku Inc (NASDAQ: 
Via Benzinga
Moderna’s (MRNA) Massive Market Cap
As could have been expected in the midst of a global pandemic, one of the most rapidly growing companies has been vaccine producer Moderna. 
Via Talk Markets
Eli Lilly, A Five-Year Analysis: How Important Is Re-Investing Dividends?
Compounding Returns In a world obsessed with price movements of stocks, it's easy to lose sight of what those prices represent -- the value of holding a company's future profit... 
Via Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
If You Invested $24,370 in This Top Stock 5 Years Ago, You'd Be Making $1,000 in Dividends This Year
Plus your investment would be worth nearly three times its original value. 
Via The Motley Fool
Eli Lilly and Company (LLY) Q2 2021 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
4 Top Stock Trades for Wednesday: Ethereum, Bitcoin, LLY, HOOD
Ethereum, Bitcoin, Eli Lilly and Robinhood were our top stock trades for Wednesday. Now, let's look at the charts after some nice movement. 
Via InvestorPlace
Lilly Stock Slips On Mixed Bag Q2 Earnings, Cuts FY21 Sales Outlook For COVID-19 Therapies
Eli Lilly And Co posted Q2 sales of $6.74 billion, beating the consensus of $6.65 billion and an increase of 23% Y/Y, 
Via Talk Markets
Exposures COVID-19
Eli Lilly: Q2 Earnings Insights
Shares of Eli Lilly (NYSE:LLY) decreased 1.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 1.06% over the... 
Via Benzinga
Another Big Earnings Week Ahead
After a monumental week of Big Tech earnings, we're in for more than a quarter of S&P 500 companies' reports, including those from Alibaba (NYSE: BABA), General Motors... 
Via Benzinga
Topics Stocks
Exposures US Equities
Lilly Stock Slips On Mixed Bag Q2 Earnings, Cuts FY21 Sales Outlook For COVID-19 Therapies
Eli Lilly And Co (NYSE: LLY) posted Q2 sales of $6.74 billion, beating the consensus of $6.65 billion and an increase of 23% Y/Y, Higher sales were driven by a 22... 
Via Benzinga
Exposures COVID-19
Eli Lilly Earnings Fall Short, Sales Top; LLY Stock Falls Slightly
Eli Lilly earnings slightly missed Q2 estimates, though the drug giant's sales edged past views. LLY stock dipped. 
Via Investor's Business Daily
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dropped around 100 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
Topics Stocks
Exposures US Equities
5 Stocks To Watch For August 3, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Alibaba Group Holding Ltd - ADR (NYSE: BABA) to report quarterly earnings at $2.24 per share on... 
Via Benzinga
Week In Review: Kumquat Signs $2 Billion US-China Deal With Lilly For Novel Immune Drugs
Kumquat Biosciences announced a $2 billion agreement with a Lilly subsidiary to discover small molecule drugs that stimulate tumor-specific immune responses in cancer patients. Lilly will make a $70... 
Via Talk Markets
Cummins Joins Call for Congressional Action Protecting Dreamers
Cummins Joins Call for Congressional Action Protecting Dreamers 
Via News Direct
Topics Immigration
Exposures COVID-19 Immigration
Lilly's Donanemab Lowers Alzheimer's-Associated Biomarkers In Patients With Early Disease
Eli Lilly And Co (NYSE: LLY) rolled out the new exploratory analyses of the Trailblazer Phase 2 trial at the Alzheimer's Association International Conference.... 
Via Benzinga
Cummins Joins Call for Congressional Action Protecting Dreamers
SOURCE: Cummins Inc. 
Via 3BL Media
Topics Immigration
Exposures COVID-19 Immigration
Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients
The FDA extended the Emergency Use Authorization (EUA) for Eli Lilly And Co's (NYSE: LLY) and Incyte Corporation's (NASDAQ: INCY) rheumatoid... 
Via Benzinga
Exposures COVID-19 Product Safety
Lilly, Kumquat Biosciences Team Up To Discover, Develop Immuno-Oncology Candidates
Loxo Oncology, a unit of Eli Lilly And Co (NYSE: LLY), and Kumquat Biosciences have announced an exclusive collaboration to discover, develop, and... 
Via Benzinga
Banned Merger
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood. 
Via Talk Markets
Cancer Biological Therapy Market Share 2021: Top Three Crucial Trends Favoring Industry Demand by 2027: Global Market Insights Inc.
Major cancer biological therapy market players include AbbVie, Merck, AstraZeneca, GlaxoSmithKline, ELI Lilly and Company, Otsuka, Pfizer, Hoffmann-La Roche, Novartis and Takeda Pharmaceuticals. 
Via Newswire.com
Topics Death
Exposures Death
Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch
Annovis bucked the trend depressing Alzheimer's stocks on Friday as ANVS stock touched a record high while SAVA stock and INMB stock fell. 
Via Investor's Business Daily
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.